CSIMarket
 


Immunic Inc   (IMUX)
Other Ticker:  
 
 

IMUX's EPS from Cont. Operations Growth by Quarter and Year

Immunic Inc 's EPS from Cont. Operations results by quarter and year




IMUX EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.80 -0.54 -0.26
III Quarter September -0.69 -0.76 -0.70 -0.82
II Quarter June -0.72 -0.82 -0.90 -1.52
I Quarter March -0.74 -1.63 -0.79 -0.22
FY   -2.15 -4.01 -2.93 -2.82



IMUX EPS from Cont. Operations third quarter 2022 Y/Y Growth Comment
Immunic Inc in the third quarter 2022 recorded EPS loss from Cont. Operations of $ -0.69 .

According to the results reported in the third quarter 2022, Immunic Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Immunic Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




IMUX EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Immunic Inc 's third quarter 2022 EPS from Cont. Operations $ -0.69 IMUX's Income Statement
Immunic Inc 's third quarter 2021 EPS from Cont. Operations $ -0.76 Quarterly IMUX's Income Statement
New: More IMUX's historic EPS from Cont. Operations Growth >>


IMUX EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Immunic Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Immunic Inc in the III. Quarter 2022 revealed EPS loss from Cont. Operations of $ -0.69 , it should be said, that current results are slight up side compare to the -0.72 in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential EPS from Cont. Operations growth. While Immunic Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q EPS from Cont. Operations Comment
Even if Immunic Inc in the III. Quarter 2022 admitted EPS loss from Cont. Operations of $ -0.69 , it should be said, that those numbers show improvement relative to the -0.72 in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential EPS from Cont. Operations growth. While Immunic Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Immunic Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -2.95 $ -3.02 $ -3.12 $ -4.01 $ -3.75
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Immunic Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Immunic Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
IMUX's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for IMUX's Competitors
EPS from Cont. Operations Growth for Immunic Inc 's Suppliers
EPS from Cont. Operations Growth for IMUX's Customers

You may also want to know
IMUX's Annual Growth Rates IMUX's Profitability Ratios IMUX's Asset Turnover Ratio IMUX's Dividend Growth
IMUX's Roe IMUX's Valuation Ratios IMUX's Financial Strength Ratios IMUX's Dividend Payout Ratio
IMUX's Roa IMUX's Inventory Turnover Ratio IMUX's Growth Rates IMUX's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-1.35%$ -1.351 
Zoetis Inc -2.59%$ -2.586 
Ironwood Pharmaceuticals inc -2.94%$ -2.941 
Universal Health Services Inc -4.91%$ -4.906 
Henry Schein Inc -5.17%$ -5.172 
Pediatrix Medical Group Inc -5.41%$ -5.405 
Charles River Laboratories International inc -7.32%$ -7.317 
Te Connectivity ltd -8.03%$ -8.027 
Synaptogenix Inc -8.51%$ -8.511 
Semler Scientific inc -9.84%$ -9.836 
Sotera Health Company-10.00%$ -10.000 
National Research Corporation-10.53%$ -10.526 
Intuitive Surgical Inc -14.95%$ -14.953 
Lemaitre Vascular Inc-16.67%$ -16.667 
Molecular Templates Inc -18.52%$ -18.519 
Regeneron Pharmaceuticals Inc -19.91%$ -19.909 
Reynolds Consumer Products Inc -25.81%$ -25.806 
Maravai Lifesciences Holdings Inc -26.09%$ -26.087 
Progyny Inc -26.32%$ -26.316 
Zynex inc -27.78%$ -27.778 
Merck and Co Inc -29.28%$ -29.282 
Organon and Co -29.92%$ -29.921 
Abbott Laboratories-30.51%$ -30.508 
Gilead Sciences Inc -30.58%$ -30.583 
West Pharmaceutical Services Inc -31.65%$ -31.646 
Alpha Pro Tech Ltd -33.33%$ -33.333 
Taitron Components Incorporated-33.33%$ -33.333 
Laboratory Corporation Of America Holdings-35.90%$ -35.902 
Lhc Group Inc-35.96%$ -35.955 
Encompass Health Corporation-36.63%$ -36.634 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RGC's Profile

Stock Price

RGC's Financials

Business Description

Fundamentals

Charts & Quotes

RGC's News

Suppliers

RGC's Competitors

Customers & Markets

Economic Indicators

RGC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071